Ovarian Cancer Immunotherapy and Personalized Medicine by Susan Morand, Monika Devanaboyina, Hannah Staats, Laura Stanbery, John Nemunaitis

Get full text

Systemic benefit of radiation therapy via abscopal effect by Daniel J. Craig, Stephanie Ambrose, Laura Stanbery, Adam Walter, Adam Walter, John Nemunaitis

Get full text

Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer by John Nemunaitis, Laura Stanbery, Adam Walter, Adam Walter, Rodney Rocconi, Philip Stephens, Philip Stephens

Get full text

Pilot Study of Combination Gemogenovatucel-T (Vigil) and Durvalumab in Women With Relapsed BRCA-wt Triple-Negative Breast or Ovarian Cancer by Minal Barve, Phylicia Aaron, Luisa Manning, Ernest Bognar, Gladice Wallraven, Staci Horvath, Laura Stanbery, John Nemunaitis

Get full text

Adenomatous polyposis coli in cancer and therapeutic implications by Olivia Noe, Louis Filipiak, Rachel Royfman, Austin Campbell, Leslie Lin, Danae Hamouda, Laura Stanbery, John Nemunaitis

Get full text

Targeted Combination of Poly(ADP-ribose) Polymerase Inhibitors and Immune Checkpoint Inhibitors Lacking Evidence of Benefit: Focus in Ovarian Cancer by Morgan Bailey, Susan Morand, Rachel Royfman, Leslie Lin, Aditi Singh, Laura Stanbery, Adam Walter, Danae Hamouda, John Nemunaitis

Get full text

Case Report: Marked Survival Advantage of Two Colorectal Cancer Patients with Liver Metastases Treated with Vigil and FOLFOX-6 by Vedin Barve, Ned Adams, Laura Stanbery, Luisa Manning, Staci Horvath, Gladice Wallraven, Ernest Bognar, Minal Barve, John Nemunaitis

Get full text

Homologous recombination proficiency in ovarian and breast cancer patients by Justin Fortune Creeden, Nisha S. Nanavaty, Katelyn R. Einloth, Cassidy E. Gillman, Laura Stanbery, Danae M. Hamouda, Lance Dworkin, John Nemunaitis

Get full text

Advances in Targeted Therapy for the Treatment of Cervical Cancer by Dean E. Watkins, Daniel J. Craig, Shahnaz D. Vellani, Ahmad Hegazi, Kaylee J. Fredrickson, Adam Walter, Laura Stanbery, John Nemunaitis

Get full text

Resident Memory T Cells and Their Effect on Cancer by Daniel J. Craig, Justin F. Creeden, Katelyn R. Einloth, Cassidy E. Gillman, Laura Stanbery, Danae Hamouda, Gerald Edelman, Lance Dworkin, John J. Nemunaitis

Get full text

Clonal Neoantigen: Emerging “Mechanism-based” Biomarker of Immunotherapy Response by John Nemunaitis, Laura Stanbery, David Willoughby, Ernest Bognar, Scott Brun, Adam Walter, Bradley J. Monk, Rodney P. Rocconi, Khalil Choucair, Robert L. Coleman

Get full text

Long-Term Follow-Up of Gemogenovatucel-T (Vigil) Survival and Molecular Signals of Immune Response in Recurrent Ovarian Cancer by Rodney P. Rocconi, Laura Stanbery, Luciana Madeira da Silva, Robert A. Barrington, Phylicia Aaron, Luisa Manning, Staci Horvath, Gladice Wallraven, Ernest Bognar, Adam Walter, John Nemunaitis

Get full text

Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance by Johnathan Oh, Minal Barve, Neil Senzer, Phylicia Aaron, Luisa Manning, Gladice Wallraven, Ernest Bognar, Laura Stanbery, Staci Horvath, Meghan Manley, John Nemunaitis, Adam Walter, Rodney P. Rocconi

Get full text

A Scalable Engineered Extracellular Matrix Platform to Expand Tumor Cells by Seongjun Moon, Dylan B. Neale, Do Hoon Kim, Malini Mukherji, Elliot Hughes, Yuxuan Deng, Fabienne Kerneis, Xiuquan Luo, Darron Tharp, Ernest Bognar, Laura Stanbery, John Nemunaitis, Tae-Hwa Chun, Joerg Lahann

Get full text

ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer by Rodney P. Rocconi, Laura Stanbery, Min Tang, Luciana Madeira da Silva, Adam Walter, Bradley J. Monk, Thomas J. Herzog, Robert L. Coleman, Luisa Manning, Gladice Wallraven, Staci Horvath, Ernest Bognar, Neil Senzer, Scott Brun, John Nemunaitis

Get full text

Author Correction: ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer by Rodney P. Rocconi, Laura Stanbery, Min Tang, Luciana Madeira da Silva, Adam Walter, Bradley J. Monk, Thomas J. Herzog, Robert L. Coleman, Luisa Manning, Gladice Wallraven, Staci Horvath, Ernest Bognar, Neil Senzer, Scott Brun, John Nemunaitis

Get full text